Antibacterial agents in infections of the central nervous system

Infect Dis Clin North Am. 2000 Jun;14(2):391-408, ix. doi: 10.1016/s0891-5520(05)70254-3.


Experimental animal models have provided information applicable to antimicrobial therapy of infections of the central nervous system. The efficacy of an antimicrobial agent in the therapy of bacterial meningitis depends on its ability to penetrate the blood-brain barrier, its activity in purulent cerebrospinal fluid, and a demonstration of rapid bactericidal activity against the offending pathogen. The recent emergence of resistant pathogens is challenging the therapy for bacterial meningitis. Various strategies for treating resistant pathogens have been evaluated in experimental animal models. Encouraging results have led to clinical trials to evaluate the efficacy of newer agents, alone or in combination with standard regimens.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / cerebrospinal fluid
  • Anti-Bacterial Agents / pharmacokinetics
  • Anti-Bacterial Agents / therapeutic use*
  • Cerebrospinal Fluid / microbiology
  • Humans
  • Meningitis, Bacterial / drug therapy*
  • Meningitis, Bacterial / microbiology


  • Anti-Bacterial Agents